Literature DB >> 6661342

Exercise-induced increments in plasma levels of propranolol and noradrenaline.

G A Hurwitz, J G Webb, T Walle, S A Bai, H B Daniell, L Gourley, C Boyd Loadholt, T E Gaffney.   

Abstract

Exercise-induced changes in the plasma levels of propranolol and noradrenaline were determined in nine volunteers. Total plasma propranolol levels were increased during submaximal treadmill exercise, with exercise-induced increments of 13 +/- 4% at 4 h after the last dose, 18 +/- 7% at 9 h and 41 +/- 5% at 16 h. Exercise-induced increments in plasma propranolol were observed after single as well as repeated doses. During exercise, increments in plasma propranolol were correlated temporally with changes in plasma noradrenaline. Exercise-induced increments in plasma noradrenaline were greater during propranolol administration than during placebo periods. The changes in plasma propranolol concentration during exercise may reflect a redistribution of propranolol at its site(s) of action.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661342      PMCID: PMC1428364          DOI: 10.1111/j.1365-2125.1983.tb02228.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  33 in total

1.  A sensitive radioenzymatic assay for norepinephrine in tissues and plasma.

Authors:  D P Henry; B J Starman; D G Johnson; R H Williams
Journal:  Life Sci       Date:  1975-02-01       Impact factor: 5.037

2.  Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism.

Authors:  E Adler-Graschinsky; S Z Langer
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

3.  Plasma volume changes following exercise and thermal dehydration.

Authors:  D L Costill; W J Fink
Journal:  J Appl Physiol       Date:  1974-10       Impact factor: 3.531

4.  The peripheral vascular effects of propranolol and related compounds.

Authors:  R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1967-02

5.  Effects of physical stress on the disposition of drugs eliminated by the liver in man.

Authors:  R D Swartz; F R Sidell; S A Cucinell
Journal:  J Pharmacol Exp Ther       Date:  1974-01       Impact factor: 4.030

6.  The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol.

Authors:  A S Nies; G H Evans; D G Shand
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

7.  Effects of heat and exercise on the elimination of pralidoxime in man.

Authors:  R D Swartz; F R Sidell
Journal:  Clin Pharmacol Ther       Date:  1973 Jan-Feb       Impact factor: 6.875

8.  Blood and muscle pH after maximal exercise in man.

Authors:  L Hermansen; J B Osnes
Journal:  J Appl Physiol       Date:  1972-03       Impact factor: 3.531

9.  Perceived exertion as an indicator of somatic stress.

Authors:  G Borg
Journal:  Scand J Rehabil Med       Date:  1970

10.  Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.

Authors:  M Ehrnebo; S Agurell; B Jalling; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

View more
  14 in total

1.  Does stress influence ampicillin concentration in serum and tissues?

Authors:  C Tesseromatis; A Trichilis; E Tsivos; J Messari; H Triantaphyllidis; D D Varonos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jul-Sep       Impact factor: 2.441

2.  Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.

Authors:  M A van Baak; J M Mooij; P M Schiffers
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Transdermal patch drug delivery interactions with exercise.

Authors:  Thomas L Lenz; Nicole Gillespie
Journal:  Sports Med       Date:  2011-03-01       Impact factor: 11.136

Review 4.  Influence of exercise on the pharmacokinetics of drugs.

Authors:  M A van Baak
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

5.  Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing.

Authors:  S W Sanders; N Haering; H Mosberg; H Jaeger
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 6.  Beta-adrenoceptor blockade and exercise. An update.

Authors:  M A Van Baak
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

7.  The quantal secretion of catecholamines is impaired by the accumulation of beta-adrenoceptor antagonists into chromaffin cell vesicles.

Authors:  Mónica S Montesinos; Marcial Camacho; J David Machado; O Humberto Viveros; Beatriz Beltrán; Ricardo Borges
Journal:  Br J Pharmacol       Date:  2010-03-05       Impact factor: 8.739

8.  Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.

Authors:  A Wellstein; D Palm; H F Pitschner; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Effects of long-acting propranolol on blood pressure and heart rate in hypertensive Chinese.

Authors:  V M Oh; B L Chia; E A Taylor
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

Review 10.  Potential interactions between exercise and drug therapy.

Authors:  Thomas L Lenz; Nancy J Lenz; Michele A Faulkner
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.